A November 2018 FDA drug safety communication warned of serious side effects associated with alemtuzumab. Alemtuzumab is also sold under the name Lemtrada and Campath. Lemtrada is commonly used to treat multiple sclerosis. Campath is commonly used to treat chronic lymphocytic leukemia, cutaneous T-cell lymphoma and T-cell lymphoma.
The FDA communication reports that serious, rare cases of stroke and arterial lining tears have occurred shortly after patients have taken Lemtrada (alemtuzumab). The FDA communication warns that these complications can lead to death or permanent disability..
The FDA, in addition to updating Lemtrada and Campath’s labeling, has also added the risk of stroke to their boxed warning. This type of FDA warning is its strongest, most prominent warning, which is also commonly referred to as a “black box warning.”
If you or a loved one has been diagnosed with arterial dissection or has suffered a hemorrhagic or ischemic stroke after taking Lemtrada or Campath, you may be entitled to financial compensation.
Contact the Lemtrada Lawsuit Attorneys of Nadrich & Cohen today for a free case evaluation, by calling 1-800-718-4658 , use the live chat feature, or complete the contact form on this page. There is no upfront cost to you. You never charge a fee for our services unless a recovery is made.
Lemtrada Side Effects
The FDA said it has identified 13 cases of Lemtrada-related cervicocephalic arterial dissection, hemorrhagic stroke and ischemic stroke worldwide since 2014. All 13 cases occurred within 13 days of Lemtrada use, and most of them occurred within one day. There were eight cases of hemorrhagic stroke, two cases of ischemic stroke, 4 cases of arterial dissection and two strokes of unspecified type. The mechanism by which alemtuzumab apparently causes these side effects is currently unknown.
The FDA said that cases of intracerebral hemorrhage and ischemic stroke have also been reported in patients who have taken Campath.
What Are The Signs Of Stroke?
- Sudden weakness or numbness in the arms, legs or face, especially only on one side of the body
- Sudden speaking difficulties, confusion or problems understanding speech
- Sudden vision problems
- Sudden dizziness, loss of coordination or balance or problems with walking
- Sudden, severe neck pain or headache
What Are The Signs Of An Arterial Dissection?
- Persistent neck pain, along the side of neck upwards toward the edge of the eye
- Severe headache
- Sharp, stabbing pain at the base of the skull
The FDA recommends that emergency treatment be sought whenever Lemtrada, Campath or alemtuzumab patients display any of the above symptoms, which can be indicative of stroke or arterial dissection.
You will never owe us any money out of your own pocket because we are contingency lawyers, meaning we only charge you a portion of any recovery we obtain for you. You will not be charged a fee if we do not obtain a recovery..
You can rest assured that we are the experts in dangerous drugs lawsuits, having obtained past verdicts and settlements of $14,250,000, $5,000,000 and $1,250,000 for victims of dangerous drugs. You can trust us to obtain for you the largest recovery possible, since we’ve obtained over $350,000,000 in recoveries for dangerous drug injury victims and other injury victims since our founding in 1990.
The law firm of Nadrich & Cohen was founded on the principle, “the client always comes first.” Your case will always receive the personalized attention it deserves since we represent only plaintiffs and limit our paralegals’ caseloads so they have plenty of time to devote to you and your case.
Request A Free Lemtrada Lawsuit Consultation Now
You may be entitled to financial compensation if you or a loved one has suffered a hemorrhagic or ischemic stroke or has been diagnosed with arterial dissection after taking Lemtrada or Campath, so call 1-800-718-4658 today for a confidential, free consultation.
Do not wait as there are strict time limits in which to make a Lemtrada or Campath claim.